1. blazefred
2. eddiebaez
3. arkadiuszbaransk
4. dddimensions
1.dddimensions 09/29/2017
Very low priced... bright future..
2.blazefred 01/26/2018
Goldman Sachs initiates as a neutral
3.eddiebaez 03/01/2018
Emergent BioSolutions Awarded One-Year CDC Contract Valued at $26 Million for Vaccinia Immune Globulin Program
4.blazefred 01/08/2018
Poor day for $EBS
5.dddimensions 02/26/2018
Emergent BioSolutions and Valneva initiate phase 1 clinical study to evaluate zika vaccine
6.dddimensions 05/29/2018
CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
7.blazefred 09/30/2017
An interesting Biotech company. Anthrax vaccine and more. ' Numbers Revealed, Reaffirms Outlook {Link}
8.eddiebaez 09/29/2017
Creeping toward $45
9.blazefred 02/27/2018
Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus
10.eddiebaez 02/26/2018
Seems they are trying to find the right balance.
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW